文献速递产科

扩展谱抗生素预防试验中剖宫产后母体感染的危险因素

Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.
PubMed 文献 · Obstet Gynecol · 2017-01-01

本研究为随机临床试验的计划二次分析,纳入2013例在破膜或临产至少4小时后行剖宫产且孕周≥24周的产妇,随机接受阿奇霉素或安慰剂。剖宫产后母体感染复合结局发生率为8.8%;校正阿奇霉素分组后,黑人种族、非横切口子宫切口、破膜时间>6小时及手术时间>49分钟与感染风险升高相关(校正OR约2),阿奇霉素与感染风险降低相关(校正OR 0.4,95%CI 0.3-0.6)。

要点

  • 剖宫产后母体感染复合结局发生率为8.8%(177/2013)。
  • 黑人种族、非横切口、破膜>6小时、手术>49分钟与感染风险升高相关(校正OR约2)。
  • 阿奇霉素与感染风险降低相关(校正OR 0.4,95%CI 0.3-0.6)。

核心结论

  • 尽管术前给予阿奇霉素为基础的扩展谱抗生素预防,剖宫产后母体感染仍是重要的致病原因,识别危险因素可能有助于指导创新性预防策略。

研究设计与样本

  • 随机临床试验的计划二次分析,纳入孕周≥24周、破膜或临产至少4小时后行剖宫产的产妇2013例,随机接受阿奇霉素(1019例)或安慰剂。
  • 所有参与者均接受标准术前预防,主要结局为产后6周内子宫内膜炎、切口感染(浅表或深部)或其他感染的复合结局。

主要发现

  • 2013例中177例(8.8%)发生剖宫产后母体感染。
  • 最终校正模型显示,与参照组相比,黑人种族、非横切口子宫切口、破膜时间>6小时及手术时间>49分钟的产妇感染风险更高(校正OR均约为2)。
  • 阿奇霉素与母体感染风险降低相关(校正OR 0.4,95%CI 0.3-0.6)。

关键数值与推荐

  • 剖宫产后母体感染复合结局:子宫内膜炎、切口感染(浅表或深部)或其他感染,发生于产后6周内。
  • 黑人种族、非横切口子宫切口、破膜时间>6小时、手术时间>49分钟与感染风险升高相关(校正OR均约为2)。
  • 阿奇霉素与感染风险降低相关(校正OR 0.4,95%CI 0.3-0.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify maternal clinical risk factors for postcesarean maternal infection in a randomized clinical trial of preincision extended-spectrum antibiotic prophylaxis. METHODS: We conducted a planned secondary analysis of a randomized clinical trial. Patients were 24 weeks of gestation or greater and delivered by cesarean after a minimum of 4 hours of ruptured membranes or labor. All participants received standard preincision prophylaxis and were randomized to receive azithromycin or placebo. The primary outcome for this analysis is maternal infection: a composite outcome of endometritis, wound infection (superficial or deep), or other infections occurring up to 6 weeks postpartum. Maternal clinical characteristics associated with maternal infection, after controlling for azithromycin assignment, were identified. These maternal factors were included in a multivariable logistic regression model for maternal infection. RESULTS: Of 2,013 patients, 1,019 were randomized to azithromycin. Overall, 177 (8.8%) had postcesarean maternal infection. In the final adjusted model, compared with the reference groups, women of black race-ethnicity, with a nontransverse uterine incision, with duration of membrane rupture greater than 6 hours, and surgery duration greater than 49 minutes, were associated higher odds of maternal infection (all with adjusted odds ratios [ORs] of approximately 2); azithromycin was associated with lower odds of maternal infection (adjusted OR 0.4, 95% confidence interval 0.3-0.6). CONCLUSION: Despite preincision azithromycin-based extended-spectrum antibiotic prophylaxis, postcesarean maternal infection remains a significant source of morbidity. Recognition of risk factors may help guide innovative prevention strategies. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT012235546.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Boggess KA, Tita A, Jauk V, et al. Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis. Obstet Gynecol. 2017. PMID: 28178058. doi:10.1097/AOG.0000000000001899

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。